Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Abatacept may help some people with alopecia areata regrow hair.

Tofacitinib may help regrow hair in alopecia areata patients.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib effectively treats Alopecia Areata.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

The drug combination significantly reduced epileptic drop attacks in patients.